{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T12:30:28Z","timestamp":1769085028582,"version":"3.49.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":1086,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aimed to determine the impact of heart failure (HF) on clinical outcomes in patients with atrial fibrillation (AF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We analysed data from Polish participants of the EURObservational Research Programme-AF General Long-Term Registry. The primary endpoint was all-cause death, and the secondary endpoints included hospital readmissions, cardiovascular (CV) interventions, thromboembolic and haemorrhagic events, rhythm control interventions, and other CV or non-CV diseases development during one-year follow up. Overall, 688 patients with available data on HF were included into analysis; 51% (n = 351) had HF; of these 48% (n = 168) had reduced ejection fraction (HFrEF), 22% (n = 77) mid-range EF (HFmrEF), and 30% (n = 106) preserved EF (HFpEF). Compared with patients without HF, those with HF had higher mortality rate (aHR 5.61; 95% CI 1.94\u201316.22, P &amp;lt; 0.01). Patients with HF (vs. without HF) had more often CV interventions (10% vs. 5.4%, P = 0.046) and events (14% vs. 7.1%, P = 0.02), and had less often atrial arrhythmia-related hospital admissions (6.8% vs. 15%, P &amp;lt; 0.01). Over follow-up, patients with HFmrEF and HFpEF had similar mortality rate versus HFrEF (aHR 0.45, 95% CI 0.13\u20131.57, P = 0.45 for HFmrEF and aHR 0.54, 95% CI 0.20\u20131.48, P = 0.54 for HFpEF). Mortality rate was similar among rhythm versus rate control group (aHR 0.34; 95% CI 0.10\u20131.16; P = 0.34).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>AF patients with HF have greater mortality rate and more CV interventions\/events. No statistically significant difference in long-term outcomes between patients with HFrEF, HFmrEF, and HFpEF highlights the need to develop therapeutic strategies targeting functional status and survival for patients with HF and AF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14130","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T01:55:33Z","timestamp":1669168533000},"page":"637-649","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Heart Failure in Patients with Atrial Fibrillation: Insights from Polish part of the EORP-AF General Long-Term Registry"],"prefix":"10.1093","volume":"10","author":[{"given":"Monika","family":"Budnik","sequence":"first","affiliation":[{"name":"First Department of Cardiology, Medical University of Warsaw , Warsaw ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Gawa\u0142ko","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Medical University of Warsaw , Warsaw ,","place":["Poland"]},{"name":"Institute of Pharmacology, West German Heart and Vascular Centre, University Duisburg-Essen , Duisburg ,","place":["Germany"]},{"name":"Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht , Maastricht ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Lodzi\u0144ski","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Medical University of Warsaw , Warsaw ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Tymi\u0144ska","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Medical University of Warsaw , Warsaw ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Oziera\u0144ski","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Medical University of Warsaw , Warsaw ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Grabowski","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Medical University of Warsaw , Warsaw ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micha\u0142","family":"Peller","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Medical University of Warsaw , Warsaw ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Wancerz","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Medical University of Warsaw , Warsaw ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Kiliszek","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Internal Diseases, Military Institute of Medicine , Warsaw ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Opolski","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Medical University of Warsaw , Warsaw ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rados\u0142aw","family":"Lenarczyk","sequence":"additional","affiliation":[{"name":"First Department of Cardiology and Angiology, Silesian Centre for Heart Disease , Zabrze ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zbigniew","family":"Kalarus","sequence":"additional","affiliation":[{"name":"Department of Cardiology, DMS in Zabrze, Medical University of Silesia , Katowice ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science, Liverpool Heart and Chest Hospital, University of Liverpool , Liverpool ,","place":["UK"]},{"name":"Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University , Aalborg ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Balsam","sequence":"additional","affiliation":[{"name":"First Department of Cardiology, Medical University of Warsaw , Warsaw ,","place":["Poland"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"2026012114124967900_ehf214130-bib-0001","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/europace\/euw295","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"18","author":"Kirchhof","year":"2016","journal-title":"Europace"},{"key":"2026012114124967900_ehf214130-bib-0002","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eut373","article-title":"A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: Baseline results of EURObservational research Programme atrial fibrillation (EORP-AF) pilot general registry","volume":"16","author":"Lip","year":"2014","journal-title":"Europace"},{"key":"2026012114124967900_ehf214130-bib-0003","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/eurheartj\/ehi694","article-title":"Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: A community-based study over two decades","volume":"27","author":"Miyasaka","year":"2006","journal-title":"Eur Heart J"},{"key":"2026012114124967900_ehf214130-bib-0004","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1161\/CIRCHEARTFAILURE.111.965681","article-title":"Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: An analysis of get with the guidelines-heart failure","volume":"5","author":"Mountantonakis","year":"2012","journal-title":"Circ Heart Fail"},{"key":"2026012114124967900_ehf214130-bib-0005","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham heart study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"2026012114124967900_ehf214130-bib-0006","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/europace\/eux301","article-title":"Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: A report from the EURObservational research Programme on atrial fibrillation (EORP-AF) long-term general registry","volume":"20","author":"Boriani","year":"2018","journal-title":"Europace"},{"key":"2026012114124967900_ehf214130-bib-0007","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the heart failure association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012114124967900_ehf214130-bib-0008","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.amjcard.2017.02.050","article-title":"Effect of atrial fibrillation on mortality, stroke risk, and quality-of-life scores in patients with heart failure (from the outcomes registry for better informed treatment of atrial fibrillation [ORBIT-AF])","volume":"119","author":"Cherian","year":"2017","journal-title":"Am J Cardiol"},{"key":"2026012114124967900_ehf214130-bib-0009","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jchf.2016.07.012","article-title":"Efficacy and safety of novel Oral anticoagulants in patients with atrial fibrillation and heart failure: A meta-analysis","volume":"4","author":"Savarese","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2026012114124967900_ehf214130-bib-0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.5603\/KP.a2015.0180","article-title":"Clinical characteristics and predictors of one-year outcome of heart failure patients with atrial fibrillation compared to heart failure patients in sinus rhythm","volume":"74","author":"Oziera\u0144ski","year":"2016","journal-title":"Kardiol Pol"},{"key":"2026012114124967900_ehf214130-bib-0011","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","article-title":"Atrial fibrillation in heart failure with preserved, mid-Range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026012114124967900_ehf214130-bib-0012","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/eurjhf\/hfs005","article-title":"Ejection fraction and outcomes in patients with atrial fibrillation and heart failure: The Loire Valley atrial fibrillation project","volume":"14","author":"Banerjee","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026012114124967900_ehf214130-bib-0013","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.005694","article-title":"Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fraction","volume":"2","author":"McManus","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"2026012114124967900_ehf214130-bib-0014","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1253\/circj.CJ-09-0254","article-title":"Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese cardiac registry of heart failure in cardiology (JCARE-CARD)","volume":"73","author":"Tsuchihashi-Makaya","year":"2009","journal-title":"Circ J"},{"key":"2026012114124967900_ehf214130-bib-0015","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: Temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"2026012114124967900_ehf214130-bib-0016","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","article-title":"Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes","volume":"203","author":"Kotecha","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012114124967900_ehf214130-bib-0017","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/ejhf.187","article-title":"The prognostic significance of atrial fibrillation in heart failure with a preserved and reduced left ventricular function: Insights from a meta-analysis","volume":"16","author":"Cheng","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026012114124967900_ehf214130-bib-0018","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jchf.2016.09.016","article-title":"Predictors and prognostic implications of incident heart failure in patients with prevalent atrial fibrillation","volume":"5","author":"Pandey","year":"2017","journal-title":"JACC Heart Fail"},{"key":"2026012114124967900_ehf214130-bib-0019","article-title":"Heart failure with reduced ejection fraction: A review of clinical status and meta-analyses of diagnosis by 3D echocardiography and natriuretic peptides-guided heart failure therapy","volume":"1","author":"Albakri","year":"2018","journal-title":"Trends Res"},{"key":"2026012114124967900_ehf214130-bib-0020","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.121.057095","article-title":"Randomized ablation-based rhythm-control versus rate-control trial in patients with heart failure and atrial fibrillation: Results from the RAFT-AF trial","volume":"145","author":"Parkash","year":"2022","journal-title":"Circulation"},{"key":"2026012114124967900_ehf214130-bib-0021","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejim.2011.05.001","article-title":"Rate vs rhythm control in patients with atrial fibrillation and heart failure: A systematic review and meta-analysis of randomised controlled trials","volume":"22","author":"Caldeira","year":"2011","journal-title":"Eur J Intern Med"},{"key":"2026012114124967900_ehf214130-bib-0022","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse","year":"2002","journal-title":"N Engl J Med"},{"key":"2026012114124967900_ehf214130-bib-0023","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa0708789","article-title":"Rhythm control versus rate control for atrial fibrillation and heart failure","volume":"358","author":"Roy","year":"2008","journal-title":"N Engl J Med"},{"key":"2026012114124967900_ehf214130-bib-0024","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/archinternmed.2012.2266","article-title":"Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation","volume":"172","author":"Ionescu-Ittu","year":"2012","journal-title":"Arch Intern Med"},{"key":"2026012114124967900_ehf214130-bib-0025","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/01.CIR.0000121736.16643.11","article-title":"Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study","volume":"109","author":"Corley","year":"2004","journal-title":"Circulation"},{"key":"2026012114124967900_ehf214130-bib-0026","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter ablation for atrial fibrillation with heart failure","volume":"378","author":"Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"2026012114124967900_ehf214130-bib-0027","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCEP.113.000806","article-title":"A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial)","volume":"7","author":"Hunter","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026012114124967900_ehf214130-bib-0028","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.jacc.2013.01.069","article-title":"A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure","volume":"61","author":"Jones","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026012114124967900_ehf214130-bib-0029","article-title":"Atrial fibrillation in heart failure patients with preserved or reduced ejection fraction. Prognostic significance of rhythm control strategy with catheter ablation","volume":"11","author":"Vecchio","year":"2019","journal-title":"J Atr Fibrillation"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.14130","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.14130","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/1\/637\/65108379\/eschf_10_1_637.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/10\/1\/637\/65108379\/eschf_10_1_637.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:14:33Z","timestamp":1769022873000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/10\/1\/637\/8304999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,11,22]]},"published-print":{"date-parts":[[2023,2,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14130","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,2]]},"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"2020-12-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}